Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Moderna (MRNA) and Nuvalent (NUVL)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quantum-Si (QSI – Research Report), Moderna (MRNA – Research Report) and Nuvalent (NUVL – Research Report).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Quantum-Si (QSI)
Alliance Global Partners analyst Scott Henry maintained a Buy rating on Quantum-Si today and set a price target of $2.50. The company’s shares closed last Tuesday at $0.95, close to its 52-week low of $0.61.
According to TipRanks.com, Henry is ranked #10568 out of 12144 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Quantum-Si with a $2.00 average price target.
See the top stocks recommended by analysts >>
Moderna (MRNA)
Bernstein analyst Courtney Breen maintained a Hold rating on Moderna yesterday and set a price target of $45.00. The company’s shares closed last Tuesday at $49.83, close to its 52-week low of $29.25.
According to TipRanks.com, Breen is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Moderna with a $36.13 average price target, representing a -28.4% downside. In a report issued on February 16, Citi also maintained a Hold rating on the stock with a $41.00 price target.
Nuvalent (NUVL)
Canaccord Genuity analyst John Newman maintained a Buy rating on Nuvalent today and set a price target of $126.00. The company’s shares closed last Tuesday at $100.22.
According to TipRanks.com, Newman is a 2-star analyst with an average return of
Currently, the analyst consensus on Nuvalent is a Strong Buy with an average price target of $142.31, representing a 44.1% upside. In a report issued on February 26, LifeSci Capital also maintained a Buy rating on the stock with a $142.00 price target.
